AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06588166 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Gut microbiome testing
Description: Gut microbiome testing for the characterization of the patient gut microbiome
Study NCT06712849 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Transcranial Random Noise Stimulation
Description: Sham transcranial random noise stimulation will be applied over the primary visual cortex (area V1) with the current ramping up for 20 seconds before ramping down for 20 seconds. The 2.0 milliamp current stimulation will occur for only a few seconds at the start and at the end of the 40 minutes.
Study NCT05188898 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MINSD and Hyaluronic acid
Description: After local anesthesia, MINSD will be performed using an ultrasonic scaler with fine tips and micro-curette; then, a hyaluronic acid-based gel will be applied to the intraosseous periodontal pockets.
Study NCT05188898 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: MINSD
Description: Only subgingival mechanical debridement (MINSD) will be performed with an ultrasonic scaler with fine tips and micro-curette.
Study NCT04270656 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Insulin pump therapy
Description: 5-day hospitalization in case of randomization in the insulin pump group (insulin pump establishing in according to the recommendations of the HAS)
Study NCT04270656 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Multi-injection treatment ( MDI ).
Description: Corresponds to an outpatient visit if the patient is randomized into the multi-injection group
Study NCT06712849 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: High Frequency Transcranial Random Noise Stimulation
Description: Non-invasive brain stimulation will involve the use of high-frequency transcranial random noise stimulation (100-640 Hz) to apply a 2.0 milliamp current over the primary visual cortex (area V1) for approximately 40 minutes with a ramp up to the maximum programmed current and ramp down of 20 seconds.
Study NCT06729931 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Pleural Fluid Quantitative C-Reactive Protein (Q-CRP) Measurement
Description: The intervention involves the measurement of Quantitative C-Reactive Protein (Q-CRP) levels in pleural fluid obtained from patients presenting with lymphocytic exudative pleural effusion. The Q-CRP test is performed using standardized laboratory methods to quantitatively analyze CRP levels, which are then compared between patients with confirmed tuberculous pleural effusion and those with malignant pleural effusion. This diagnostic approach aims to evaluate the efficacy of pleural fluid Q-CRP as a biomarker to differentiate between these two conditions. No therapeutic or invasive interventions are introduced as part of this study beyond routine diagnostic procedures.
Study NCT06646939 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PT and OT with a simulated environment
Description: Upon admission to the inpatient rehabilitation unit, participants will undergo a physical and occupational therapy evaluation. The evaluations will include the outcome measures chosen to track for this study (10-meter walk test and Quality Indicators). If a patient meets inclusion/exclusion criteria, informed written consent will be obtained. Throughout the patient's stay, therapists will have the opportunity to perform community integration treatments using the simulated environment. This could include activities such as negotiating a curb, crossing a street, or shopping at a marketplace. The therapist will document the amount of time (units billed) spent performing these interventions. The research investigators will not act as a patient's therapist throughout their admission.
Study NCT05950776 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MVA-SARS-2-S
Description: Vaccination with MVA-SARS-2-S
Study NCT05950776 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05130502 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Foam roller
Description: The investigators use Foam roller to 3 muscle groups per leg then conduct a dynamic warm up program and conduct performance tests
Study NCT05130502 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kinesiotape
Description: The investigators use Kinesiotape to 3 muscle groups per leg, wait 45 minutes for bring out the effects then conduct a dynamic warm up program and conduct performance tests
Study NCT06730893 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: share decision aids
Description: card news and videos related to general knowledge and treatment of low-risk thyroid cancer
Study NCT06731660 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education with personalized performance feedback
Description: Education about proper otitis media diagnosis following criteria from the American Academy of Pediatrics with personalized performance feedback on otitis media diagnosis and treatment rates delivered via email
Study NCT06731660 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Use of digital otoscope
Description: Use of the Wispr digital otoscope to diagnose otitis media in place of a traditional visual otoscope
Study NCT05230095 — intervention group
Intervention type: BEHAVIORAL
Intervention: social cognition tests
Description: The evaluation of social cognition will be carried out using questionnaires and a point lights computer test. During the computer test, participants have to watch several short sequences of interactions between two silhouettes and give an interpretation of the scene.~Patients will be evaluated twice: one time before the surgery and a second time 1 year after surgery.~Healthy volunteers will be evaluated only one time.
Study NCT05230095 — intervention group
Intervention type: BEHAVIORAL
Intervention: Quality of life self-questionnaire
Description: Quality of life will be assessed using a self-administered questionnaire in the patients group only.
Study NCT05764577 — intervention group
Intervention type: PROCEDURE
Intervention: DIEP flap surgery
Description: Removal off the DIEP flap followed by closure of the rectus sheath and abdominal skin.
Study NCT05261230 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vedic Counselling
Description: Trauma focused Vedic Counselling intervention was delivered by trained and experienced therapist of Yoga and Vedanta.12-week sessions were provided on one to one bases on personalised approach.
Study NCT05261230 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Care
Description: The active control group received standard psychosocial care provided by the participating psychologists and psychiatrists.
Study NCT05712655 — intervention group
Intervention type: OTHER
Intervention: Measurement of bilateral electromyographic activity of Masseter and Anterior Temporalis muscles.
Description: Assessment was done by surface electromyography (sEMG) device.
Study NCT06731361 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Systematic multidisciplinary medication review + ACP (SMMR+)
Description: The intervention is a training in medication assessment. The goal is to align prescription with the treatment goals of nursing home patients which are set in advance care planning conversations. The training consists of 2 components:~1. Medication assessment with the use of the ReNeWAL criteria (adjusted STOPP/START criteria, tailored to nursing home patients with a limited life expectancy)~2. Advance care planning component. Discussing medication in line with the treatment goals set in advance care planning conversations.~Healthcare professionals receive the training in combination with supporting tools (pocket card) and educational material (the ReNeWAL criteria and PowerPoint slides of the training if requested). Also, intervision moments are planned.
Study NCT06730750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986490
Description: Specified dose on specified days.
Study NCT06730750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Specified dose on specified days.
Study NCT05400889 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tofacitinib
Description: Tofacitinib 5mg was taken orally once or twice a day and baricitinib 2mg or 4mg was taken orally once a day for 6 months.
Study NCT01240928 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MSK-2206
Description: Level 1: MK-2206 135mg weekly
Study NCT01240928 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Exemestane
Description: Level 1: Exemestane - 25mg daily
Study NCT01240928 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Goserelin
Description: Level 1: Goserelin- 3.6mg monthly for pre-menopausal subjects only
Study NCT06731387 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmaceutical technical assistants supported medication dispensation on the hospital ward
Description: Pharmaceutical technical assistants (PTAs) visit the hospital ward for two hours in the morning or afternoon to dispense medications for admitted patients for the following day. Night nurses then complete any final additions or adjustments as needed.
Study NCT05127824 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous alpha-DC1/TBVA vaccine
Description: Dendritic cells (DC) are derived from autologous (the subject's own) mononuclear cells in the peripheral blood obtained from the PRBC. In this case, biologic product and biologic substance are the same. The vaccine will be manufactured in the HCC-IMPCL, under cGMP conditions.
Study NCT05127824 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Description: Cabozantinib tablets are supplied as film coated tablets containing cabozantinib malate equivalent to 20 mg and 60 mg of cabozantinib and contain microcrystalline cellulose, lactose anhydrous, hydoxypropyl cellulose, croscarmellose sodium, colloidal silicon dioxide, magnesium stearate and Opadry® yellow. The 60 mg tablets are oval and the 20 mg tablets are round. Doses of 40 mg will comprise two 20-mg tablets.
Study NCT05320198 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DISC-0974
Description: DISC-0974 is administered subcutaneously.
Study NCT05223842 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Promoting Positive Emotions (F-PPE)
Description: F-PPE is an 8-session dyadic intervention designed to enhance positive emotionality and buffer against the effects of stress on anhedonia in children. The intervention will be administered online through videoconferencing sessions with a clinician to mothers and their children.
Study NCT05223842 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Written Information
Description: Mothers assigned to the Written Information condition will receive email newsletters providing resources relevant to depression.
Study NCT05127993 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Passive Talaris Demonstrator
Description: The amputee will walk with the passive Talaris Demonstrator, a novel prosthetic foot, designed and built by Axiles Bionics.
Study NCT05127993 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Passive Talaris Demonstrator
Description: The amputee will walk with the passive Talaris Demonstrator, a novel prosthetic foot, designed and built by Axiles Bionics.
Study NCT04356859 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Albumin Human
Description: Addition of albumin during acute resuscitation following burn injury
Study NCT04566159 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBI-CHW
Description: 2 sessions of computer delivered counseling + nicotine replacement therapy and CHW follow up post hospitalization up to twice weekly for up to 8 weeks
Study NCT04566159 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard Care
Description: Standard tobacco treatment care offered by the inpatient care
Study NCT05312125 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: backward downhill walking
Description: Children in the intervention group will take backward downhill walking program plus to routine physiotherapy.
Study NCT05312125 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: routine physiotherapy
Description: Children in one of the groups will take routine physiotherapy programme
Study NCT04848662 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BDA MDI (PT027) 160/180 μg
Description: Combination Product: Budesonide/albuterol sulfate metered-dose inhaler 80/90 μg per puff. Two puffs to administer 160/180 μg dose.
Study NCT04848662 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pulmicort Respules 0.5 MG/ML Inhalation Suspension
Description: Budesonide 0.5 mg/ml. Each 2 ml Respule contains 1 mg budesonide.
Study NCT04815486 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Description: Active rTMS in 10 daily sessions in two weeks of sequential application of: 90% RMT at 1Hz, 1000 pulses/day, 25s inter train on M1 of lesioned hemisphere and 90% RMT at 10Hz, 1000 pulses/day, 50s inter train on M1 of healthy hemisphere.
Study NCT04815486 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Motor Imagery (MI) through a Brain-Computer Interface (BCI) training platform in Virtual Reality (VR) with NeuRow
Description: It will consist of a combination of the bilateral rTMS protocol and the MI-neurofeedback training. During this therapy, the patient received 10 consecutive daily sessions of bilateral rTMS (Monday to Friday, two weeks), with the same stimulation parameters as another therapy, and 12 non-consecutive sessions of MI-neurofeedback (three times a week for four weeks). The first 6 MI-neurofeedback sessions were carried out after bilateral stimulation with rTMS (i.e., rTMS as a priming method during the first two weeks), and the last 6 sessions, without rTMS as prior priming during the last two weeks.
Study NCT04876885 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Educational video
Description: Three two-minute educational videos about COVID-19 vaccine development and dissemination
Study NCT05980819 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sustainability lecture and opportunity to create a project
Description: Pure education
Study NCT06348745 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ultrasound
Description: 5. Transthoracic ultrasound for both right and left diaphragm during inspiration and expiration.
Study NCT06053047 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bluedrop Monitoring Service (BMS)
Description: Remote use of ThermoVisual monitoring
Study NCT05858398 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: pharmacokinetics blood sample assessment
Description: pharmacokinetics blood sample assessment during the first exposure to docetaxel
Study NCT04840498 — intervention group
Intervention type: BEHAVIORAL
Intervention: Autism Research
Description: Measuring aspects such as self esteem, social skills, and social anxieties.
Study NCT05424094 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: multi-professional group programme 'kinderleicht'
Description: 12-16 children/adolescents who participate in the multi-professional group programme 'kinderleicht' receive coaching in the areas of behaviour, exercise, nutrition and medicine from qualified professionals on fridays during 11 months.
Study NCT05526222 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Jaktinib Hydrochloride Tablet
Description: Orally administered, twice a day
Study NCT05526222 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Jaktinib Hydrochloride Tablet
Description: Orally administered, twice a day
Study NCT06376032 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EndeavorOTC®
Description: EndeavorOTC is an over the counter digital therapeutic designed to improve attention function as measured by computer-based testing in patients 18 and older with primarily inattentive or combined type ADHD, who have a demonstrated attention issue. EndeavorOTC utilizes the same proprietary technology underlying EndeavorRx®, an FDA-authorized prescription digital therapeutic indicated to improve attention function in children ages 8-17. EndeavorOTC is deployed on mobile devices and incorporates adaptive, simultaneous cognitive tasks in a consumer-grade action videogame-based platform with high-quality graphics and reward mechanisms.
Study NCT04938934 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lipids infusion
Description: Lipids infusion via intestinal tube
Study NCT04938934 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham infusion
Description: Sham infusion via intestinal tube
Study NCT05313815 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Moderate hypofractionated boost to the prostate with pelvic RT (external beam radiotherapy)
Description: External beam radiotherapy- 60 Gy in 20 fractions to the prostate, 48 Gy in 20 fractions to the pelvis, 68 Gy in 20 fraction optional boost to prostatic dominant intraprostatic lesion, 55 Gy in 20 fraction optional boost to involved pelvic lymph nodes
Study NCT04705519 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel Combined With Bevacizumab
Description: Nab-paclitaxel 150mg/m2 ，iv drip, d1, Bevacizumab 5mg/kg, iv drip, d1, q2w.
Study NCT05647109 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT05657132 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: herbal intracanal medication paste
Description: study the effect of costus herbal paste on enterococcus faecalis bacteria
Study NCT05657132 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Meta paste
Description: compare the effect of Costus paste with meta paste in reducing the number of enterococcus faecalis
Study NCT06620432 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Low segment hysterotomy
Description: A low segment hysterotomy is a surgical procedure in which an incision is made in the lower segment of the uterus, typically during a cesarean section or other uterine surgeries. This approach is preferred because the lower uterine segment is thinner and less vascular, reducing the risk of bleeding and complications during and after the procedure. The incision is typically horizontal.
Study NCT06620432 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Low segment hysterotomy
Description: A low segment hysterotomy is a surgical procedure in which an incision is made in the lower segment of the uterus, typically during a cesarean section or other uterine surgeries. This approach is preferred because the lower uterine segment is thinner and less vascular, reducing the risk of bleeding and complications during and after the procedure. The incision is typically horizontal.
Study NCT06620432 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High segment hysterotomy
Description: A high segment hysterotomy is a surgical procedure involving an incision in the upper segment of the uterus.
Study NCT06620432 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Crossed hysterorrhaphy
Description: Crossed hysterorrhaphy is a surgical technique used to close the uterine incision following a hysterotomy, particularly during cesarean sections. In this method, the sutures are placed in a crossed or X-shaped pattern, which helps to evenly distribute tension across the incision site.
Study NCT06620432 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Crossed hysterorrhaphy
Description: Crossed hysterorrhaphy is a surgical technique used to close the uterine incision following a hysterotomy, particularly during cesarean sections. In this method, the sutures are placed in a crossed or X-shaped pattern, which helps to evenly distribute tension across the incision site.
Study NCT06620432 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Non-Crossed hysterorrhaphy
Description: Non-crossed hysterorrhaphy is a surgical technique used to close a uterine incision, typically after a hysterotomy, such as during a cesarean section. In this method, the sutures are placed in a linear, parallel fashion rather than in a crossed or X-shaped pattern
Study NCT06309849 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual physiotherapy intervention( cervical traction, suboccipital release, muscle energy technique)
Description: Manual physiotherapy intervention( cervical traction, suboccipital release, muscle energy technique) strengthening exercises for neck muscles, ultrasound with parameters 5 min × 3 times × 4 weeks, 1 MHz, continuous: 1.5 W/cm2; pulsed: 2.5 W/cm2.
Study NCT06309849 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Manual physiotherapy intervention( cervical traction, suboccipital release, muscle energy technique)
Description: Manual physiotherapy intervention( cervical traction, suboccipital release, muscle energy technique) strengthening exercises for neck muscles, ultrasound with parameters 5 min × 3 times × 4 weeks, 1 MHz, continuous: 1.5 W/cm2; pulsed: 2.5 W/cm2.
Study NCT06086522 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: QN-302
Description: Phase 1 dose-finding study, the study design is for QN-302 to be given once a week, intravenously over 60 min, on Day 1, Day 8, and Day 15 of a 28-Day cycle.
Study NCT04816097 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone phosphate
Description: 4 doses of dexamethasone 6mg IM 48h before elective CS.
Study NCT04845061 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Nebivolol Tablets
Description: cardio selective beta-1 blocker
Study NCT04845061 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nebivolol Tablets
Description: cardio selective beta-1 blocker